<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2022-4-85-93</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-1545</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Регенеративная медицина и клеточные технологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Regenerative Medicine and Cell Technologies</subject></subj-group></article-categories><title-group><article-title>Апоптотические мононуклеарные клетки костного мозга ускоряют регенерационные процессы в печени после обширной резекции</article-title><trans-title-group xml:lang="en"><trans-title>Apoptotic bone marrow-derived mononuclear cells accelerate liver regeneration after extended resection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Онищенко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Onishchenko</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никольская</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolskaya</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гоникова</surname><given-names>З. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Gonikova</surname><given-names>Z. Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гоникова Залина Залимгериевна</p><p>123182, Москва, ул. Щукинская, д. 1</p><p>Тел. (966) 188-33-33</p></bio><bio xml:lang="en"><p>Zalina Gonikova</p><p>1, Shchukinskaya str., Moscow, 123182, Russian Federation</p><p>Phone: (966) 188-33-33</p></bio><email xlink:type="simple">zalina3392@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирсанова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirsanova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шагидулин</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shagidulin</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Севастьянов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sevastianov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>09</day><month>08</month><year>2022</year></pub-date><volume>24</volume><issue>4</issue><fpage>85</fpage><lpage>93</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Онищенко Н.А., Никольская А.О., Гоникова З.З., Кирсанова Л.А., Шагидулин М.Ю., Севастьянов В.И., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Онищенко Н.А., Никольская А.О., Гоникова З.З., Кирсанова Л.А., Шагидулин М.Ю., Севастьянов В.И.</copyright-holder><copyright-holder xml:lang="en">Onishchenko N.A., Nikolskaya A.O., Gonikova Z.Z., Kirsanova L.A., Shagidulin M.Y., Sevastianov V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/1545">https://journal.transpl.ru/vtio/article/view/1545</self-uri><abstract><sec><title>Цель</title><p>Цель: на модели обширной резекции печени (ОРП) сравнить эффективность регенерационных процессов в печени при использовании апоптотических мононуклеарных клеток костного мозга (аМККМ) и интактных мононуклеарных клеток костного мозга (иМККМ) от здоровых животных.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Крыс-самцов породы Вистар (n = 77) с моделью ОРП (70–75%) разделили на 3 группы: группа 1 – контроль с однократным внутрибрюшинным введением физиологического раствора, группа 2 – с однократным внутрибрюшинным введением несортированных иМККМ в дозе 30–35 × 106 и группа 3 – с однократным внутрибрюшинным введением аМККМ в той же дозе. В динамике контролировали восстановление биохимических показателей функции и массы печени, а также возникающие микроструктурные изменения гепатоцитов в гистологических препаратах, оценивая митотическую активность гепатоцитов в течение первых 7–10 дней после ОРП.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что в группе 2 и в группе 3 по сравнению с группой 1 отсутствовала летальность после моделирования ОРП, а также имела место более быстрая нормализация биохимических показателей функции печени (к 10–14-м суткам). Митотическая активность гепатоцитов в группе 3 резко возрастала уже на 1-е сутки, и митотический индекс (МИ) в среднем составлял 14‰, достигая в отдельных экспериментах 20,9‰; в контроле к этому сроку МИ оставался на исходном уровне, а в группе 2 МИ составил только 3,2‰. В группе 3 отмечено также более быстрое восстановление массы печени после ОРП до исходных значений уже к 8–10-м суткам, тогда как в группе 2 – к 12–14-м суткам, а в группе 1 – к 17–20-м суткам. Было высказано предположение, что более выраженное повышение эффективности регенерационных процессов в печени после ОРП в группе 3 после применения аМККМ обусловлено высвобождением из этих клеток большого спектра образовавшихся паракринных факторов, в том числе различных классов молекул РНК, участвующих в регенерационном процессе.</p></sec><sec><title>Заключение</title><p>Заключение. аМККМ обладают более эффективным адаптивным и регуляторным потенциалом по сравнению с иМККМ, т. к. ускоренно формируют в клетках поврежденной печени перестройки, обеспечивающие более раннее и мощное включение адресной регенерационной программы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to compare the efficiency of regenerative processes in the liver using apoptotic bone marrow-derived mononuclear cells (BMMCs) and intact BMMCs from healthy animals on an extended liver resection (ELR) model.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Male Wistar rats (n = 77) with an ELR model (70–75%) were divided into 3 groups: group 1 (control with a single intraperitoneal injection of saline), group 2 (single intraperitoneal injection of unsorted intact BMMCs at a dose of 30–35 × 106, and group 3 (single intraperitoneal injection of apoptotic BMMCs at the same dose). Restoration of biochemical parameters of liver function and mass, as well as the emerging microstructural changes in hepatocytes in histological preparations, were monitored by assessing hepatocyte mitotic activity (MA) during the first 7–10 days after ELR.</p></sec><sec><title>Results</title><p>Results. It was found that in groups 2 and 3, as compared with group 1, there was no death after ELR modeling, and that the biochemical parameters of liver function normalized more rapidly (at days 10–14). Hepatocyte MA in group 3 sharply increased as early as on day 1, and mitotic index (MI) averaged 14‰, reaching 20.9‰ in some experiments; MI in the control group remained at the baseline by this time, while in group 2, MI was only 3.2‰. In group 3, liver mass recovered more rapidly after ELR to baseline values already at days 8–10, whereas the recovery was at day 12–14 and day 17–20 in group 2 and group 1, respectively. It was suggested that the more pronounced increase in the efficiency of regenerative processes in the liver after ELR in group 3 after using apoptotic BMMCs was due to the release from these cells of a large spectrum of formed paracrine factors, including various classes of RNA molecules involved in the regeneration process.</p></sec><sec><title>Conclusion</title><p>Conclusion. Apoptotic BMMNCs have a more effective adaptive and regulatory potential than intact BMMCs because reorganizations are rapidly formed in the damaged liver cells, providing an early and more powerful activation of the targeted regenerative program.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>апоптотические клетки костного мозга</kwd><kwd>регенерация</kwd><kwd>резекция печени</kwd></kwd-group><kwd-group xml:lang="en"><kwd>apoptotic bone marrow cells</kwd><kwd>regeneration</kwd><kwd>liver resection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lin CW, Chen YS, Lin CC, Chen YJ, Lee PH, Kuo PL et al. Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy. Sci Rep. 2015 Oct 30; 5: 15807. doi: 10.1038/srep15807.</mixed-citation><mixed-citation xml:lang="en">Lin CW, Chen YS, Lin CC, Chen YJ, Lee PH, Kuo PL et al. Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy. Sci Rep. 2015 Oct 30; 5: 15807. doi: 10.1038/srep15807.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Y, Wang B, Zhou H, Dang S, Jin M, Shi Y et al. Autophagy is required for maintenance of liver progenitor cell functionality. Cell Physiol Biochem. 2015; 36 (3): 1163–1174. https://doi.org/10.1159/000430287.</mixed-citation><mixed-citation xml:lang="en">Cheng Y, Wang B, Zhou H, Dang S, Jin M, Shi Y et al. Autophagy is required for maintenance of liver progenitor cell functionality. Cell Physiol Biochem. 2015; 36 (3): 1163–1174. https://doi.org/10.1159/000430287.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lv H, Fan X, Wang L, Feng H, Ci X. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. Int J Biol Macromol. 2018 Nov; 119: 240–248. doi: 10.1016/j.ijbiomac.2018.07.101.</mixed-citation><mixed-citation xml:lang="en">Lv H, Fan X, Wang L, Feng H, Ci X. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. Int J Biol Macromol. 2018 Nov; 119: 240–248. doi: 10.1016/j.ijbiomac.2018.07.101.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Oami T, Watanabe E, Hatano M, Teratake Y, Fujimura L, Sakamoto A et al. Blocking liver autophagy accelerates apoptosis and mitochondrial injury in hepatocytes and reduces time to mortality in a murine sepsis model. Shock. 2018 Oct; 50 (4): 427–434. https://doi.org/10.1097/shk.0000000000001040.</mixed-citation><mixed-citation xml:lang="en">Oami T, Watanabe E, Hatano M, Teratake Y, Fujimura L, Sakamoto A et al. Blocking liver autophagy accelerates apoptosis and mitochondrial injury in hepatocytes and reduces time to mortality in a murine sepsis model. Shock. 2018 Oct; 50 (4): 427–434. https://doi.org/10.1097/shk.0000000000001040.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shen Y, Malik SA, Amir M, Kumar P, Cingolani F, Wen J et al. Decreased Hepatocyte Autophagy Leads to Synergistic IL-1β and TNF Mouse Liver Injury and Inflammation. Hepatology. 2020 Aug; 72 (2): 595–608. doi: 10.1002/hep.31209.</mixed-citation><mixed-citation xml:lang="en">Shen Y, Malik SA, Amir M, Kumar P, Cingolani F, Wen J et al. Decreased Hepatocyte Autophagy Leads to Synergistic IL-1β and TNF Mouse Liver Injury and Inflammation. Hepatology. 2020 Aug; 72 (2): 595–608. doi: 10.1002/hep.31209.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ruart M, Chavarria L, Campreciós G, Suárez-Herrera N, Montironi C, Sergi Guixé-Muntet et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol. 2019 Mar; 70 (3): 458–469. doi: 10.1016/j.jhep.2018.10.015.</mixed-citation><mixed-citation xml:lang="en">Ruart M, Chavarria L, Campreciós G, Suárez-Herrera N, Montironi C, Sergi Guixé-Muntet et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol. 2019 Mar; 70 (3): 458–469. doi: 10.1016/j.jhep.2018.10.015.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho AB, Quintannilha LF, Dias AS et al. Bone marrow multipotent mesenchymal stem cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells. 2008; 26: 1307–1314. https://doi.org/10.1126/science.284.5411.143.</mixed-citation><mixed-citation xml:lang="en">Carvalho AB, Quintannilha LF, Dias AS et al. Bone marrow multipotent mesenchymal stem cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells. 2008; 26: 1307–1314. https://doi.org/10.1126/science.284.5411.143.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dai LJ, Li HY et al. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009; 2 (1): 16–25. https://doi.org/10.1016/j.clinbiochem.2007.04.017.</mixed-citation><mixed-citation xml:lang="en">Dai LJ, Li HY et al. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009; 2 (1): 16–25. https://doi.org/10.1016/j.clinbiochem.2007.04.017.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD. The dying stem cell hypothesis: immune odulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol. 2005; 46: 1799–1802. https://doi.org/10.1016/j.jacc.2005.07.053.</mixed-citation><mixed-citation xml:lang="en">Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD. The dying stem cell hypothesis: immune odulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol. 2005; 46: 1799–1802. https://doi.org/10.1016/j.jacc.2005.07.053.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ankersmit HJ, Hoetzenecker K, Dietl W et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest. 2009; 39: 445–456. https://doi.org/10.1111/j.1365-2362.2009.02111.x.</mixed-citation><mixed-citation xml:lang="en">Ankersmit HJ, Hoetzenecker K, Dietl W et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest. 2009; 39: 445–456. https://doi.org/10.1111/j.1365-2362.2009.02111.x.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Beer L, Mildner M, Gyöngyösi M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair. Apoptosis. 2016; 21: 1336–1353. doi 10.1007/s10495-016-1292-8.</mixed-citation><mixed-citation xml:lang="en">Beer L, Mildner M, Gyöngyösi M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair. Apoptosis. 2016; 21: 1336–1353. doi 10.1007/s10495-016-1292-8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016; 1416: 123–146. https://doi.org/10.1007/978-1-4939-3584-0_7.</mixed-citation><mixed-citation xml:lang="en">Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016; 1416: 123–146. https://doi.org/10.1007/978-1-4939-3584-0_7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sirois I, Raymond MA, Brassard N et al. Caspase-3- dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication. Cell Death Differ. 2011; 18: 549–562. https://doi.org/10.1038/cdd.2010.126.</mixed-citation><mixed-citation xml:lang="en">Sirois I, Raymond MA, Brassard N et al. Caspase-3- dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication. Cell Death Differ. 2011; 18: 549–562. https://doi.org/10.1038/cdd.2010.126.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011; 17: 860–866. https://doi.org/10.1038/nm.2385.</mixed-citation><mixed-citation xml:lang="en">Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011; 17: 860–866. https://doi.org/10.1038/nm.2385.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Beer L, Zimmermann M, Mitterbauer A et al. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep. 2015; 5: 16662. https://doi.org/10.1038/srep16662.</mixed-citation><mixed-citation xml:lang="en">Beer L, Zimmermann M, Mitterbauer A et al. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep. 2015; 5: 16662. https://doi.org/10.1038/srep16662.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007; 104: 14080–14085. https://doi.org/10.1073/pnas.0700326104.</mixed-citation><mixed-citation xml:lang="en">Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007; 104: 14080–14085. https://doi.org/10.1073/pnas.0700326104.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology. 2011; 53: 306–316. https://doi.org/10.1002/hep.24029.</mixed-citation><mixed-citation xml:lang="en">Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology. 2011; 53: 306–316. https://doi.org/10.1002/hep.24029.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ельчанинов АВ, Фатхудинов ТХ. Регенерация печени млекопитающих: Межклеточные взаимодействия. М.: Наука, 2020; 126.</mixed-citation><mixed-citation xml:lang="en">Yel’chaninov AV, Fatkhudinov TKh. Regeneratsiya pecheni mlekopitayushchikh: Mezhkletochnyye vzaimodeystviya. M.: Nauka, 2020; 126.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко НА, Фоменко ЕВ, Никольская АО, Гоникова ЗЗ, Шагидулин МЮ, Балясин МВ и др. К механизму активации восстановительных процессов в печени при использовании общей РНК клеток костного мозга. Вестник трансплантологии и искусственных органов. 2020; XXII (3): 134–142.</mixed-citation><mixed-citation xml:lang="en">Onishchenko NA, Fomenko EV, Nikolskaya AO, Gonikova ZZ, Shagidulin MYu, Balyasin MV et al. Activation of regenerative processes in the liver when using cell-bone marrow total RNA. Russian Journal of Transplantology and Artificial Organs. 2020; 22 (3): 134–142. https://doi.org/10.15825/1995-1191-2020-3-134-142.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Korf-Klingebiel M, Kempf T, Sauer T et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J. 2008; 29: 2851–2858. https://doi.org/10.1093/eurheartj/ehn456.</mixed-citation><mixed-citation xml:lang="en">Korf-Klingebiel M, Kempf T, Sauer T et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J. 2008; 29: 2851–2858. https://doi.org/10.1093/eurheartj/ehn456.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Потапнев МП. Аутофагия, апоптоз, некроз клеток и иммунное распознавание своего и чужого. Иммунология. 2014; 2: 95–102</mixed-citation><mixed-citation xml:lang="en">Potapnev MP. Autophagia, apoptosis, cell necrosis and immune recognition of their and someone else’s. Immunology. 2014; 2: 95–102.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Гоникова ЗЗ, Никольская АО, Кирсанова ЛА, Шагидулин МЮ, Онищенко НА, Севастьянов ВИ. Сравнительный анализ эффективности стимуляции процессов регенерации печени клетками костного мозга и общей РНК этих клеток. Вестник трансплантологии и искусственных органов. 2019; 21 (1): 113–121.</mixed-citation><mixed-citation xml:lang="en">Gonikova ZZ, Nikolskaya AO, Kirsanova LA, Shagidulin MYu, Onishchenko NA, Sevastianov VI. The comparative analysis of the effectiveness of stimulation of liver regeneration by bone marrow cells and total RNA of these cells. Russian Journal of Transplantology and Artificial Organs. 2019; 21 (1): 113–121. (In Russ.) https://doi.org/10.15825/1995-1191-2019-1-113-121.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Газизов ИМ, Гумерова АА, Киясов АП. Апоптоз в регенерационном гистогенезе печени после частичной гепатэктомии у крыс. Гены и клетки. 2015; 10 (3): 22–26.</mixed-citation><mixed-citation xml:lang="en">Gazizov IM, Gumerova AA, Kiyasov AP. Apoptosis in regenerative histogenesis of the liver after partial hepatectomy in rats. Genes and cells. 2015; 10 (3): 22–26. eLIBRARY ID: 26280345.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Budd RC. Death receptors coupe to both cell proliferations and apoptosis. J Clin Jnvest. 2002 Fev 15; 109 (4): 437–442. doi: 10.1172/JCI15077.</mixed-citation><mixed-citation xml:lang="en">Budd RC. Death receptors coupe to both cell proliferations and apoptosis. J Clin Jnvest. 2002 Fev 15; 109 (4): 437–442. doi: 10.1172/JCI15077.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
